http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021154334-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91943488b68ac64c91e5a094819621d6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y402-01001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
filingDate 2020-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d519c0f52721854fd1fc0030374bc43a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b516044650956c7ffbe969c1cd10fe74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3891f373b44f2b1f9321b63aa9c8b8ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5474903f5e51f71804815794a2643b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a602ab64e17bdf4299ecf2afa574be18
publicationDate 2021-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021154334-A1
titleOfInvention Dual-targeted carbonic anhydrase ix complex and contrast agent thereof
abstract Disclosed herein are a dual-targeted carbonic anhydrase IX complex, a contrast agent comprising the same, and a synthesizing method thereof. The dual-targeted carbonic anhydrase IX complex includes a carbonic anhydrase IX (CA9) binding peptide, a sulfonamide derivative, and a metal chelating agent. The dual-targeted carbonic anhydrase IX complex has potential for use as a molecular nuclear drug.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023153847-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023155454-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023111350-A2
priorityDate 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226509015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226666738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235096749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID393901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4736784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226534911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442612004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226789712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4961948

Total number of triples: 48.